Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Issa Nebie

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Ebiomedicine|July 3, 2015
Malaria Vaccines: Progressing on a Bumpy RoadGiampietro Corradin, Issa Nebie
Tropical Medicine & International Health : TM & IH|November 7, 2009
Low-high season variation in Plasmodium falciparum erythrocyte binding antigen 175 (eba-175) allelic forms in malaria endemic area of Burkina FasoIssiaka Soulama, Edith C Bougouma, Amidou Diarra, et al.
Vaccine|July 31, 2019
Immunogenicity of a recombinant fusion construct composed of intrinsically unstructured, low polymorphic segments derived from merozoite surface protein 2 and trophozoite exported protein 1Regis Wendpayangde Tiendrebeogo, Ralf Spallek, Wulf Oehlmann, et al.
Pathogens (Basel, Switzerland)|October 25, 2024
Force of Infection (FOI) and Multiplicity of Infection (MOI) in <i>Plasmodium falciparum</i> Infected Children Aged 1.5-12 Years Living in the Malaria Endemic Area of Banfora, Burkina FasoEmilie S Badoum, Ludovic Kouraogo, Amidou Diarra, et al.
Journal of Nanobiotechnology|September 8, 2017
The use of a P. falciparum specific coiled-coil domain to construct a self-assembling protein nanoparticle vaccine to prevent malariaChristopher P Karch, Tais A P F Doll, Sara M Paulillo, et al.
The Journal of Infectious Diseases|June 1, 2007
Children in Burkina Faso who are protected by insecticide-treated materials are able to clear drug-resistant parasites better than unprotected childrenDiadier A Diallo, Colin Sutherland, Issa Nebie, et al.
Malaria Journal|March 24, 2012
Antibodies to malaria vaccine candidates are associated with chloroquine or sulphadoxine/pyrimethamine treatment efficacy in children in an endemic area of Burkina FasoAmidou Diarra, Issa Nebie, Alfred Tiono, et al.
Acta Tropica|February 3, 2020
Antibody response to Schistosoma haematobium and other helminth species in malaria-exposed populations from Burkina FasoValentina D Mangano, Claretta Bianchi, Mireille Ouedraogo, et al.
Human Immunology|August 12, 2009
HLA-DRB1 and -DQB1 loci in three west African ethnic groups: genetic relationship with sub-Saharan African and European populationsPatrizia Lulli, Valentina D Mangano, Annamaria Onori, et al.
Journal of Parasitology Research|December 4, 2015
Clinical Variation of Plasmodium falciparum eba-175, ama-1, and msp-3 Genotypes in Young Children Living in a Seasonally High Malaria Transmission Setting in Burkina FasoIssiaka Soulama, Samuel S Sermé, Edith C Bougouma, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Ebiomedicine|July 3, 2015
Malaria Vaccines: Progressing on a Bumpy RoadGiampietro Corradin, Issa Nebie
Tropical Medicine & International Health : TM & IH|November 7, 2009
Low-high season variation in Plasmodium falciparum erythrocyte binding antigen 175 (eba-175) allelic forms in malaria endemic area of Burkina FasoIssiaka Soulama, Edith C Bougouma, Amidou Diarra, et al.
Vaccine|July 31, 2019
Immunogenicity of a recombinant fusion construct composed of intrinsically unstructured, low polymorphic segments derived from merozoite surface protein 2 and trophozoite exported protein 1Regis Wendpayangde Tiendrebeogo, Ralf Spallek, Wulf Oehlmann, et al.
Pathogens (Basel, Switzerland)|October 25, 2024
Force of Infection (FOI) and Multiplicity of Infection (MOI) in <i>Plasmodium falciparum</i> Infected Children Aged 1.5-12 Years Living in the Malaria Endemic Area of Banfora, Burkina FasoEmilie S Badoum, Ludovic Kouraogo, Amidou Diarra, et al.
Journal of Nanobiotechnology|September 8, 2017
The use of a P. falciparum specific coiled-coil domain to construct a self-assembling protein nanoparticle vaccine to prevent malariaChristopher P Karch, Tais A P F Doll, Sara M Paulillo, et al.
The Journal of Infectious Diseases|June 1, 2007
Children in Burkina Faso who are protected by insecticide-treated materials are able to clear drug-resistant parasites better than unprotected childrenDiadier A Diallo, Colin Sutherland, Issa Nebie, et al.
Malaria Journal|March 24, 2012
Antibodies to malaria vaccine candidates are associated with chloroquine or sulphadoxine/pyrimethamine treatment efficacy in children in an endemic area of Burkina FasoAmidou Diarra, Issa Nebie, Alfred Tiono, et al.
Acta Tropica|February 3, 2020
Antibody response to Schistosoma haematobium and other helminth species in malaria-exposed populations from Burkina FasoValentina D Mangano, Claretta Bianchi, Mireille Ouedraogo, et al.
Human Immunology|August 12, 2009
HLA-DRB1 and -DQB1 loci in three west African ethnic groups: genetic relationship with sub-Saharan African and European populationsPatrizia Lulli, Valentina D Mangano, Annamaria Onori, et al.
Journal of Parasitology Research|December 4, 2015
Clinical Variation of Plasmodium falciparum eba-175, ama-1, and msp-3 Genotypes in Young Children Living in a Seasonally High Malaria Transmission Setting in Burkina FasoIssiaka Soulama, Samuel S Sermé, Edith C Bougouma, et al.
Pageof 5